National Pharmaceutical Council elects Boehringer Ingelheim executive as chairman
WASHINGTON — Boehringer Ingelheim SVP managed markets Jeff Huth has been elected by the National Pharmaceutical Council as chairman of the board for 2013-2014, the organization said Friday.
Huth has served as a member of the NPC’s board since 2009 and has previously had the positions of vice chairman and treasurer. The NPC, founded in 1953, describes itself as a health policy research organization focused on the advancement of science and medical innovation.
"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading healthcare policy research organization," NPC president Dan Leonard said. "We’re looking forward to having Jeff play an even more active role in leading NPC’s efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals and the use of real-world evidence."
NACDS’ Anderson: November Health Affairs adds more ‘heft’ to community pharmacy support
ARLINGTON, Va. — The National Association of Chain Drug Stores is hailing articles in the November 2013 edition of Health Affairs that urge greater reliance on pharmacy in new healthcare delivery models and that recommend re-alignment of federal and state policies to empower pharmacy patient care.
“Articles in this edition of Health Affairs read like a playbook for leveraging the value, expertise and accessibility of community pharmacies, for the good of patients nationwide,” stated NACDS president and CEO Steve Anderson. “Pharmacists are well-known for helping patients use medicines and stay healthy, and we are seeing greater and greater awareness of the innovative pharmacy services that can do even more to improve patient health and quality of life.”
With a theme of “Redesigning the Health Care Workforce,” the November 2013 Health Affairs includes articles on the role of pharmacists in accountable care organizations and other new healthcare delivery models; on the need to restructure scope-of-practice regulations for health professions; and on strategies to address the physician shortage.
“This edition of Health Affairs adds even more heft to the mounting support for the vision that pharmacies should be empowered to help shape the healthcare delivery system of tomorrow, in partnership with doctors, nurses and other allies in patient care. It builds on the substantial case for leveraging pharmacy’s strengths as the face of neighborhood health care,” Anderson stated.
Reports: Sen. David Vitter seeks to link vote on compounding bill to bid to prevent Obamacare employer contributions for lawmakers, staff
NEW YORK — Sen. David Vitter, R-La., is holding up a vote on a measure that would strengthen regulations on compounding pharmacies in order to alter a provision of the Patient Protection and Affordable Care Act, according to published reports.
Bloomberg reported that Vitter was trying to couple a vote on the compounding law with a proposal to deny lawmakers and their staffs employer contributions for health insurance purchased on the health insurance exchanges set up under ACA. Senators may have to spend a week on work that would otherwise take minutes, according to Bloomberg.
Every senator except Vitter has pledged to vote for the bill, H.R. 3204, which would subject pharmacies that engage in sterile compounding to Food and Drug Administration regulations. The FDA has sought to regulate the pharmacies since last year’s outbreak of fungal meningitis linked to the New England Compounding Center, which sickened hundreds and killed dozens.